Standard BioTools Inc.
Символ: LAB
NASDAQ
2.48
USDПазарна цена днес
-2.6485
Съотношение P/E
-0.0759
Коефициент PEG
949.96M
MRK Cap
- 0.00%
Доходност на DIV
Standard BioTools Inc. (LAB) финансови отчети
Баланс
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 540.59 | 114.9 | 165.8 | 28.5 | |||||||||||||||||||
balance-sheet.row.short-term-investments | 153.26 | 63.2 | 84.5 | 0 | |||||||||||||||||||
balance-sheet.row.net-receivables | 65.84 | 19.7 | 17.3 | 18.3 | |||||||||||||||||||
balance-sheet.row.inventory | 87.05 | 20.5 | 21.5 | 20.8 | |||||||||||||||||||
balance-sheet.row.other-current-assets | 13.47 | 3.1 | 4.3 | 4.5 | |||||||||||||||||||
balance-sheet.row.total-current-assets | 706.95 | 158.2 | 208.8 | 72.1 | |||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 225.27 | 54.9 | 59.5 | 65.2 | |||||||||||||||||||
balance-sheet.row.goodwill | 425.11 | 106.3 | 106.3 | 106.4 | |||||||||||||||||||
balance-sheet.row.intangible-assets | 23.06 | 1.4 | 12.6 | 27.9 | |||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 448.17 | 107.7 | 118.9 | 134.3 | |||||||||||||||||||
balance-sheet.row.long-term-investments | 3.19 | 0.8 | 1 | 1 | |||||||||||||||||||
balance-sheet.row.tax-assets | -2.38 | 0 | -1 | -1 | |||||||||||||||||||
balance-sheet.row.other-non-current-assets | 8.63 | 1.5 | 3.1 | 3.7 | |||||||||||||||||||
balance-sheet.row.total-non-current-assets | 682.88 | 164.9 | 181.5 | 203.1 | |||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.total-assets | 1389.83 | 323.1 | 390.3 | 275.2 | |||||||||||||||||||
balance-sheet.row.account-payables | 28.76 | 9.2 | 7.9 | 10.6 | |||||||||||||||||||
balance-sheet.row.short-term-debt | 88.42 | 63.9 | 5.8 | 9.9 | |||||||||||||||||||
balance-sheet.row.tax-payables | 5.88 | 1.2 | 1.2 | 1.4 | |||||||||||||||||||
balance-sheet.row.long-term-debt-total | 282.5 | 4 | 96.9 | 101.8 | |||||||||||||||||||
Deferred Revenue Non Current | 63 | 14.3 | 18.2 | 24.1 | |||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 3.96 | - | - | - | |||||||||||||||||||
balance-sheet.row.other-current-liab | 73.44 | 20.6 | 15.3 | 13.6 | |||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 1317.14 | 50.5 | 428.3 | 131.1 | |||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 138.56 | 30.4 | 37.8 | 40.6 | |||||||||||||||||||
balance-sheet.row.total-liab | 1568.89 | 159.9 | 471.8 | 180.6 | |||||||||||||||||||
balance-sheet.row.preferred-stock | 1245.01 | 311.3 | 311.3 | 0 | |||||||||||||||||||
balance-sheet.row.common-stock | 0.33 | 0.1 | 0.1 | 0.1 | |||||||||||||||||||
balance-sheet.row.retained-earnings | -3884.65 | -1000.8 | -926.1 | -736 | |||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -7.05 | -2.2 | -1.9 | -0.9 | |||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 2467.3 | 854.8 | 535.2 | 831.4 | |||||||||||||||||||
balance-sheet.row.total-stockholders-equity | -179.06 | 163.2 | -81.5 | 94.6 | |||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 1389.83 | 323.1 | 390.3 | 275.2 | |||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.total-equity | -179.06 | 163.2 | -81.5 | 94.6 | |||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 1389.83 | - | - | - | |||||||||||||||||||
Total Investments | 154.85 | 64 | 84.5 | 1 | |||||||||||||||||||
balance-sheet.row.total-debt | 401.3 | 98.2 | 102.7 | 111.6 | |||||||||||||||||||
balance-sheet.row.net-debt | 13.97 | 46.5 | 21.3 | 83.2 |
Отчет за паричните потоци
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -74.66 | -74.7 | -190.1 | -59.2 | |||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 15.18 | 15.2 | 15 | 15.6 | |||||||||||||||||||
cash-flows.row.deferred-income-tax | -13.9 | 6.3 | 0 | 0 | |||||||||||||||||||
cash-flows.row.stock-based-compensation | 13.12 | 13.1 | 14.9 | 16.1 | |||||||||||||||||||
cash-flows.row.change-in-working-capital | 1.79 | 1.8 | -15.5 | -19.9 | |||||||||||||||||||
cash-flows.row.account-receivables | -2.99 | -3 | 1.1 | 6.7 | |||||||||||||||||||
cash-flows.row.inventory | -4.91 | -4.9 | -8.5 | -4.8 | |||||||||||||||||||
cash-flows.row.account-payables | 1.62 | 1.6 | -2.8 | 1.3 | |||||||||||||||||||
cash-flows.row.other-working-capital | 8.07 | 8.1 | -5.3 | -23.2 | |||||||||||||||||||
cash-flows.row.other-non-cash-items | 15.18 | -5 | 86.3 | 3.4 | |||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -43.29 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -2.83 | -2.8 | -3.8 | -13.3 | |||||||||||||||||||
cash-flows.row.acquisitions-net | -31.13 | 0 | 84.3 | 0 | |||||||||||||||||||
cash-flows.row.purchases-of-investments | -94.9 | -94.9 | -137.3 | 0 | |||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 117.96 | 118 | 53 | 0 | |||||||||||||||||||
cash-flows.row.other-investing-activites | 23.07 | 0 | -84.3 | 1.3 | |||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 20.24 | 20.2 | -88.1 | -11.9 | |||||||||||||||||||
cash-flows.row.debt-repayment | -2.08 | -2.1 | -6.8 | -0.5 | |||||||||||||||||||
cash-flows.row.common-stock-issued | 0.83 | 0.8 | 225 | 1.5 | |||||||||||||||||||
cash-flows.row.common-stock-repurchased | -5.41 | -5.4 | -0.6 | -1.8 | |||||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | -0.3 | |||||||||||||||||||
cash-flows.row.other-financing-activites | -0.06 | -0.1 | 13.2 | 17.1 | |||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -6.81 | -6.8 | 230.8 | 16 | |||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0.03 | 0 | -0.4 | 0 | |||||||||||||||||||
cash-flows.row.net-change-in-cash | -29.82 | -29.6 | 52.9 | -40.1 | |||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 389.71 | 51.7 | 82.3 | 29.5 | |||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 419.54 | 81.3 | 29.5 | 69.5 | |||||||||||||||||||
cash-flows.row.operating-cash-flow | -43.29 | -43.3 | -89.4 | -44.1 | |||||||||||||||||||
cash-flows.row.capital-expenditure | -2.83 | -2.8 | -3.8 | -13.3 | |||||||||||||||||||
cash-flows.row.free-cash-flow | -46.12 | -46.1 | -93.2 | -57.3 |
Ред за отчет за приходите
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 106.34 | 106.3 | 97.9 | 130.6 | |||||||||||||||||||
income-statement-row.row.cost-of-revenue | 56.1 | 55.9 | 60.9 | 61.2 | |||||||||||||||||||
income-statement-row.row.gross-profit | 50.24 | 50.5 | 37.1 | 69.4 | |||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||
income-statement-row.row.research-development | 25.87 | - | - | - | |||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.other-expenses | 6.96 | 7 | -12.3 | 7.6 | |||||||||||||||||||
income-statement-row.row.operating-expenses | 114.43 | 113.5 | 153.3 | 136.8 | |||||||||||||||||||
income-statement-row.row.cost-and-expenses | 170.53 | 169.4 | 214.2 | 198 | |||||||||||||||||||
income-statement-row.row.interest-income | 0 | 0 | 4.3 | 0.3 | |||||||||||||||||||
income-statement-row.row.interest-expense | 4.57 | 4.6 | 4.3 | 3.8 | |||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -7.66 | -11.2 | -76.7 | 3.8 | |||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||
income-statement-row.row.other-operating-expenses | 6.96 | 7 | -12.3 | 7.6 | |||||||||||||||||||
income-statement-row.row.total-operating-expenses | -7.66 | -11.2 | -76.7 | 3.8 | |||||||||||||||||||
income-statement-row.row.interest-expense | 4.57 | 4.6 | 4.3 | 3.8 | |||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 17.44 | 15.2 | 2.7 | 23.2 | |||||||||||||||||||
income-statement-row.row.ebitda-caps | -48.58 | - | - | - | |||||||||||||||||||
income-statement-row.row.operating-income | -70.12 | -63 | -116.2 | -67.5 | |||||||||||||||||||
income-statement-row.row.income-before-tax | -74.2 | -74.2 | -192.9 | -63.7 | |||||||||||||||||||
income-statement-row.row.income-tax-expense | 0.45 | 0.5 | -2.8 | -4.4 | |||||||||||||||||||
income-statement-row.row.net-income | -74.66 | -74.7 | -190.1 | -59.2 |
Често задавани въпроси
Какво е Standard BioTools Inc. (LAB) общи активи?
Standard BioTools Inc. (LAB) общите активи са 323067000.000.
Какъв е годишният приход на предприятието?
Годишните приходи са 53555000.000.
Какъв е маржът на печалбата на предприятието?
Маржът на печалбата на фирмата е -0.578.
Какъв е свободният паричен поток на компанията?
Свободният паричен поток е -0.578.
Какъв е маржът на нетната печалба на предприятието?
Маржът на нетната печалба е -0.702.
Какъв е общият приход на предприятието?
Общият приход е -0.659.
Каква е Standard BioTools Inc. (LAB) нетна печалба (нетен доход)?
Нетната печалба (нетният доход) е -74656000.000.
Какъв е общият дълг на фирмата?
Общият дълг е 98210000.000.
Какъв е броят на оперативните разходи?
Оперативните разходи са 113489000.000.
Какъв е броят на паричните средства на фирмата?
Паричните средства на предприятието са 51704000.000.